Literature DB >> 658127

Pharmacological and biochemical properties of isomeric yohimbine alkaloids.

G A Lambert, W J Lang, E Friedman, E Meller, S Gershon.   

Abstract

The stereochemical and pharmacological properties of yohimbine and some of its isomers are briefly reviewed. Several pharmacological and physical properties of a selection of the isomers have been determined with a view to elucidating which might be important in the elaboration of the known behavioral effects produced by them. Activity is not dependent upon lipid solubility or on the ease of access to the central nervous system. The isomers are weak inhibitors of rat-brain acetylcholinesterase and weak antagonists at muscarinic cholinergic receptors. In the rat brain in vitro they do not possess significant monoamine oxidase-inhibiting properties nor do they inhibit the uptake of serotonin. They are relatively potent antagonists of 5HT on the rat isolated fundus preparation and their potency in this preparation may be related to their ability to produce behavioral and cardiovascular effects in man and dogs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658127     DOI: 10.1016/0014-2999(78)90220-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

2.  Is the sympathoexcitatory effect of yohimbine determined by brain yohimbine concentration?

Authors:  Y J Kuo; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

3.  Evidence that serotonin receptors are involved in the anticonvulsant effect of yohimbine in mice.

Authors:  N Ludvig; L György; E S Vizi
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Binding of yohimbine stereoisomers to alpha-adrenoceptors in rat liver and human platelets.

Authors:  N Ferry; M Goodhardt; J Hanoune; T Sevenet
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

5.  Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.

Authors:  M Berlan; R Le Verge; J Galitzky; P Le Corre
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

6.  The pharmacokinetic properties of yohimbine in the conscious rat.

Authors:  J W Hubbard; S L Pfister; A M Biediger; T C Herzig; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

7.  Isomeric yohimbine alkaloids block calcium-activated K+ channels in medullary thick ascending limb cells of rabbit kidney.

Authors:  M Cornejo; S E Guggino; A Sastre; W B Guggino
Journal:  J Membr Biol       Date:  1989-01       Impact factor: 1.843

8.  The mechanism of yohimbine-induced renin release in the conscious rat.

Authors:  S L Pfister; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

9.  Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.

Authors:  A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

10.  Different alpha-adrenoceptors modulate the release of 5-hydroxytryptamine and noradrenaline in rat cortex.

Authors:  C Ennis
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.